Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

3.5%

11 terminated/withdrawn out of 318 trials

Success Rate

96.2%

+9.6% vs industry average

Late-Stage Pipeline

46%

146 trials in Phase 3/4

Results Transparency

78%

215 of 275 completed trials have results

Key Signals

9 recruiting215 with results7 terminated4 withdrawn

Enrollment Performance

Analytics

N/A

97(32.6%)

Phase 4

77(25.8%)

Phase 3

69(23.2%)

Phase 2

41(13.8%)

Phase 1

13(4.4%)

Early Phase 1

1(0.3%)

298Total

N/A(97)

Phase 4(77)

Phase 3(69)

Phase 2(41)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (318)

Showing 20 of 318 trials

NCT07074977Phase 2Active Not Recruiting

Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)

Role: lead

NCT07720726Phase 4Not Yet Recruiting

Impact of Dysport on PMFF Donor Scar

Role: collaborator

NCT04162496Not ApplicableCompleted

Restylane Refyne for Correction of Horizontal Neck Rhytides

Role: collaborator

NCT04717934Not ApplicableCompleted

Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906

Role: lead

NCT07566286Not ApplicableNot Yet Recruiting

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Role: lead

NCT04921345Phase 2Completed

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Role: lead

NCT07660835Phase 2Not Yet Recruiting

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis

Role: lead

NCT07047638Not ApplicableActive Not Recruiting

A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine

Role: lead

NCT06665477Not ApplicableActive Not Recruiting

Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple Hollowing

Role: lead

NCT05463978Completed

Sculptra Chart Review

Role: lead

NCT06357221Phase 4Completed

A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

Role: lead

NCT06988618Recruiting

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

Role: lead

NCT04365387Phase 2Completed

A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

Role: lead

NCT05148000Phase 3Completed

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Role: lead

NCT05777759Not ApplicableCompleted

Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

Role: lead

NCT05691972Not ApplicableCompleted

Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing

Role: lead

NCT05110287Completed

To Evaluate Effectiveness and Safety of GP0109 for Jawline Definition

Role: lead

NCT06015217Phase 4Completed

A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash

Role: lead

NCT05622851Not ApplicableCompleted

Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers

Role: lead

NCT03713203Not ApplicableRecruiting

PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).

Role: collaborator